The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 levelIssam Ben Sahra, Frédéric Bost, Kathiane Laurent et al.|Oncogene|2008Cited by 852
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1Isaam Ben Sahra, Frédéric Bost, Claire Regazzetti et al.|Cancer Research|2011Cited by 620
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer CellsIssam Ben Sahra, Frédéric Bost, Kathiane Laurent et al.|Cancer Research|2010Cited by 528
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaLise Willems, Didier Bouscary, Nathalie Jacque et al.|Blood|2013Cited by 286
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemiaLise Willems, Jérôme Tamburini, Olivier Hermine et al.|Leukemia|2011Cited by 161